I am as excited as everyone on here. But lets for a moment forget all the amazing things cydy is doing besides hiv. All you have to ask yourself is will leronlimab be approved for combo therapy(likely mono as well)? If in your mind the answer is yes then the stock is easily worth $15-20/ share. The day to day flux doesnt mean anything and the shorters cant change the results of the phase 3 trials. Very soon we will have basket. And in march hopefully there will be BTD. Longen is a curve ball that potentially could catalyze many other things. All NP has to do now is get the BLA filed. From there the market will naturally take over. Just my .02 . Im still in it and bought more when the shorters shorted us to .80, if it happens again i will go in bigger